Advanced search
Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 76, 2021 - Issue 5
Submit an article Journal homepage
165
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

Wolff Parkinson White and recreational (meth)amphetamine use: a potentially lethal combination

B. Aspeslagha Department of Emergency Medicine, Ghent University Hospital, Ghent, BelgiumCorrespondence[email protected]
,
P. Calleb Department of Emergency Medicine, AZ Maria Middelares, Ghent, Belgium;c Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumORCID Iconhttps://orcid.org/0000-0003-2024-8276
ORCID Icon &
J. De Pooterd Department of Cardiology, Ghent University Hospital, Ghent, Belgium
Pages 406-409 | Published online: 03 Apr 2020

References

  • Cole JC, Sumnall HR. Altered states: the clinical effects of Ecstasy. Pharmacol Ther. 2003;98(1):35–58.
  • Burgess C, O’Donohoe A, Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. Eur Psychiatry. 2000;15(5):287–294.
  • Milroy CM, Clark JC, Forrest AR. Pathology of deaths associated with “ecstasy” and “eve” misuse. J Clin Pathol. 1996;49(2):149–153.
  • Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ. 2001;165(7):917–928.
  • Mende I, Böhm R, Regenthal R, et al. Cardiac arrest caused by an ecstasy intoxication. Anasthesiol Intensivmed Notfallmed Schmerzther. 2005;40(12):762–765.
  • Scheinman MM. History of Wolff-Parkinson-White syndrome. PACE. 2005;28(2):152–156.
  • Obeyesekere M, Gula LJ, Skanes AC, et al. Risk of sudden death in Wolff-Parkinson-White syndrome: how high is the risk? Circulation. 2012;125(5):659–660.
  • Dreifus LS, Haiat R, Watanabe Y, et al. Ventricular fibrillation. A possible mechanism of sudden death in patients and Wolff-Parkinson-White syndrome. Circulation. 1971;43(4):520–527. .
  • Pappone C, Vicedomini G, Manguso F, et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation. 2012;125(5):661–668. .
  • Olen MM, Baysa SJ, Rossi A, et al. Wolff-Parkinson-White Syndrome: a stepwise deterioration to sudden death. Circulation. 2016;133(1):105–106. .
  • Timmermans C, Smeets JL, Rodriguez LM, et al. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1995;76(7):492–494. .
  • Brugada J, Keegan R. Asymptomatic ventricular pre-excitation: between sudden cardiac death and catheter ablation. Arrhythmia Electrophysiol. 2018;7(1):32–38.
  • Ghuran A. The cardiac complications of recreational drug use. West J Med. 2000;173(6):412–415.
  • Ghuran A, Nolan J. Recreational drug misuse: issues for the cardiologist. Heart. 2000;83(6):627–633.
  • Hall AP, Henry JA. Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. 2006;96(6):678–685.
  • Madhok A, Boxer R, Chowdhury D. Atrial fibrillation in an adolescent—the agony of ecstasy. Pediatr Emerg Care. 2003;19(5):348–349.
  • Suarez RV, Riemersma R. “Ecstasy” and sudden cardiac death. Am J Forensic Med Pathol. 1988;9(4):339–341.
  • Erowid. MDA Dosage [web page]. 2000 [cited 2017 Sept 06]. Available from:https://erowid.org/chemicals/mda/mda_dose.shtml.
  • European Resuscitation Council. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care - An international consensus on science. Part 8: advanced challenges in resuscitation. Section 2: toxicology in emergency cardiovascular care. Resuscitation. 2000;46(1–3):261–266. .
  • Bougouin W, Cariou A. Should we ‘block’ refractory ventricular fibrillation? Resuscitation. 2016;107:A9–A10.
  • Lee YH, Lee KJ, Min YH, et al. Refractory ventricular fibrillation treated with esmolol. Resuscitation. 2016;107:150–155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.